Skip to content

MOSAIC ULTRA® 305U23 (UDI 00885074253305)Recalls & reported problems

Medtronic, Inc. · VALVE 305U23 MOSAIC AOR ULTRA US · Class 3 · Implant

All models of MOSAIC ULTRA (40)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
8
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00885074253305), received between Aug 6, 2018 and Mar 10, 2026 — classified as 8 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (4 reports).

3 other recalls cover devices cleared under the same FDA submission (P990064); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information4
  • Gradient Increase3
  • Adverse Event Without Identified Device or Use Problem2
  • Biocompatibility1
  • Calcified1

Patient problems

  • Aortic Valve Stenosis4
  • Insufficient Information3
  • Aortic Valve Insufficiency/ Regurgitation1
  • Calcium Deposits/Calcification1
  • Complaint, Ill-Defined1
  • Complete Heart Block1
  • Host-Tissue Reaction1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 10, 2026Gradient Increase

    IT WAS REPORTED THAT 15 YEARS AND 6 MONTHS POST IMPLANT OF THIS 23MM AORTIC BIOPROSTHETIC VALVE, THE PATIENT IS BEING EVALUATED FOR A TRANSCATHETER VALVE-IN-VALVE REPLACEMENT. THE REASON FOR EVALUATION WAS REPORTED AS GRADIENT INCREASE. NO INTERVENTION OR ADVERSEPATIENT EFFECTS WERE REPORTED. SUBSEQUENTLY, THE PATIENT SUCCESSFULLY HAD AN AORTIC VALVE-IN-VALVE REPLACEMENT WITH A TRANSCATHETER VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 24561333 ↗
  • InjuryOct 30, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS REPORTED THAT 12 YEARS AND 2 MONTHS POST IMPLANT OF THIS 23MM AORTIC BIOPROSTHETIC VALVE, A 23MM TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE. THE REASON FOR INTERVENTION WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 23426019 ↗
  • InjuryDec 27, 2022Gradient Increase; Gradient Increase

    MEDTRONIC RECEIVED INFORMATION THAT 14 YEARS AND 6 MONTHS POST IMPLANT OF THIS 23MM AORTIC BIOPROSTHETIC VALVE, IT WAS REPORTED THAT THE PATIENT DEVELOPED MODERATE AORTIC STENOSIS, SEVERE AORTIC INSUFFICIENCY, EJECTION FRACTION OF 20% AND POSSIBLE VEGETATION/MASS ON THE AORTIC VALVE. A MEAN GRADIENT OF 39MMHG AND AORTIC VALVE AREA (AVA) OF 0.57CM^2 WERE REPORTED AND THE PATIENT IS BEING EVALUATED FOR A TRANSCATHETER VALVE-IN-VALVE REPLACEMENT. NO INTERVENTION OR ADVERSE PATIENT EFFECTS WERE REPORTED. SUBSEQUENTLY 4 MONTHS LATER, THE 23MM AORTIC BIOPROSTHETIC VALVE WAS EXPLANTED AND REPLACED WITH A 27MM AORTIC BIOPROSTHETIC VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Aortic Valve Insufficiency/ Regurgitation; Aortic Valve Stenosis

    MAUDE report 16056947 ↗
  • InjuryOct 18, 2022Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT 11 YEARS AND 10 MONTHS POST IMPLANT OF THIS 23 MM AORTIC BIOPROSTHETIC VALVE, THE PATIENT IS BEING EVALUATED FOR A TRANSCATHETER VALVE-IN-VALVE REPLACEMENT. THE REASON FOR EVALUATION WAS NOT REPORTED. NO INTERVENTION OR ADVERSE PATIENT EFFECTS WERE REPORTED. SUBSEQUENTLY, ON THE SAME DAY, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE. THE REASON FOR INTERVENTION WAS REPORTED AS AORTIC STENOSIS WITH A MEAN GRADIENT OF 41 MMHG AND A PEAK GRADIENT OF 65 MMHG. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Aortic Valve Stenosis

    MAUDE report 15623485 ↗
  • InjuryAug 16, 2021Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT APPROXIMATELY 12 YEARS AND 5 MONTHS POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE. THE REASON FOR INTERVENTION WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Aortic Valve Stenosis; Insufficient Information

    MAUDE report 12324160 ↗
  • InjuryOct 17, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT 1 DAY POST IMPLANT OF THIS 23MM BIOPROSTHETIC AORTIC VALVE, A PERMANENT PACEMAKER WAS IMPLANTED IN THE PATIENT. THE REASON FOR THE PERMANENT PACEMAKER IMPLANT WAS REPORTED AS COMPLETE HEART BLOCK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Complete Heart Block

    MAUDE report 9205384 ↗
  • InjuryOct 17, 2019Calcified; Biocompatibility; Insufficient Device Problem Information; Calcified; Biocompatibility; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT 9 YEARS 4 MONTHS POST IMPLANT OF THIS 23MM AORTIC BIOPROSTHETIC VALVE, THE VALVE WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC BIOPROSTHETIC VALVE DUE TO STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Aortic Valve Stenosis; Calcium Deposits/Calcification; Host-Tissue Reaction

    MAUDE report 9205118 ↗
  • InjuryAug 6, 2018Gradient Increase; Adverse Event Without Identified Device or Use Problem; Gradient Increase

    MEDTRONIC RECEIVED INFORMATION THAT SEVEN YEARS AND TEN MONTHS POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE DUE TO INCREASED GRADIENTS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Complaint, Ill-Defined; No Known Impact Or Consequence To Patient

    MAUDE report 7753992 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P990064. One submission often covers many models, so check the product and lot details in each record.

  • Z-1880-2019 · May 21, 2019 · Terminated
    Mosaic 310 Bioprosthesis, Mitral, REF 310C29 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
  • Z-1881-2019 · May 21, 2019 · Terminated
    Mosaic 310 Bioprosthesis, Mitral, REF 310C31 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
  • Z-1225-2009 · Jan 26, 2009 · Terminated
    Medtronic Mosaic Porcine Bioprostheses with Cinch, Heart Valve; Model 305; Catalog #s 305C21AA, 305C2701, 305C2301, 305C2501, and 305C2901; Sterile LC; Rx only; Medtronic Inc 710 M

Other heart-valve, non-allograft tissue devices

All heart-valve, non-allograft tissue devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page